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Variable Ventilatory Support 
n (%)
ICU LOS 
(days)
(days)
(days)
Survival (4-year)' 
(%)
Age (yrs) <70 >70 <70 >70 <70 >70 <70 >70
COPD 25 (15) 17 (35) 6* 10* 15 24 81 56
No-COPD 36 (8) 19(15) 4 5 11 16 92 85
Smoker 27 (12) 6(23) 5 11 12 28 87 60
Non-Smoker 34 (9) 30(19) 4 6 12 16 91 80
FEV} (L) 
<2.0 9(13) 6(30) 5 7 14* 17 76* 24*
2.Q-3.0 24 (12) 9(12) 5 7 12 16 87 80
>3.0 6(3) 2(10) 4 5 10 15 94 93
*p  < 0.05 (univariate/multivariate log-rank tests), t  Kaplan-Meler method
Preoperative FEVi significantly affected LOS in the hospital only in the 
patients <70 years of age (p = 0.0001). Delayed extubation {> 48 hrs) had 
resulted in prolonged LOS in the ICU and in the hospital for patients <70 
years (p = 0.0001, p = 0. 0001, respectively) and patients >70 years (p = 
0.0001, p = 0.0001, respectively). The 4-year survival after CABG for young 
and old patients was significantly influenced by the level of preoperative FEVi 
(p  = 0.0004, p = 0.0282, respectively). We conclude that preoperative FEVi 
is  a significant predictor of 4-year survival In the young and aged individuals 
undergoing CABG.
Is Serotonin an Unexpected Cause of Arterial 
Graft Spasm? Dynamic vs Static Evaluation of 
Porcine internal Thoracic Arteries
W.D. Montgomery, J.L. Balien, C.J. Riordan, A. Ali, W.P. Santamore,
P*A. Spence, University of Louisville, Louisville, KY, USA
W e compared the effect of serotonin (5HT) and norepinephrine (NE) on 
internal thoracic artery (ITA) spasm in both a dynamic perfusion system and 
static arterial ring preparation. Porcine ITAs (N =* 12, 2,0-2.5 mm) were 
mounted on a computer controlled perfusion apparatus. Inflow pressure 
(B0 mmHg) and outflow resistance were adjusted to simulate high {80-100 
mL/min) and normal (15-20 mL/min) graft flow. Pressure and flows were 
examined at baseline and after adding NE and 5HT. In addition, rings {N = 
15,3.0 mm) were mounted on a tension gauge and contractions in response 
to  NE and 5HT were obtained.
H ow  State Distal Pressure (mmHg) Flow (ml/min) ED50 (-log M)
Baseline Final Baseline Final
15,6 ±1.9 
99,4 ±5.0
N E  Treated ITAs (N = 5, 1(T9 to 10~5 M)
NORM 78.0 ±  0.6 77.6 ±0.5
HIGH ' 63.2 ±2.2  27.0 ±1.9*
6H T Treated ITAs (N « 7, 1Cr5 to 10~5 M)
NORM 77.2 ±  2.2 57.8 ±7.5* 19.1 ±7.9
HtGH 60.3 ±3.8  21.9 ±2.2* 78.7 ±4.4
15.3 ±1.7
45.4 ± 2.7*
NoResponse 
8.04 ± 0.58
10.9 ±0.6* 6.35 ±0.55 
26,7 ± 3.6* 6.59 ± 0.34
Mean ±SE, *p < 0,05 compared to Baseline
Under high graft fiow conditions, NE and 5HT caused significant de­
creases in flow and distal pressure with 5HT the most potent (66.1% |  in 
flow). Under normal graft flow conditions, NE caused no decrease in flow or 
distal pressure whereas 5HT caused a significant decrease in flow (42.9% I )  
and distal pressure. Static rings treated with NE and 5HT gave similar dose 
response curves with no significant differences in ED50 (NE: 6.71 ±  0.1 vs 
5HT: 6.92 ±  0 .1). These results suggests an interaction between flow and 
5HT which may augment its capacity as a vasoconstrictor. Graft flow may 
be an important but overlooked element in the generation of spasm induced 
by endogenous vasoconstrictor substances. The clinical importance of 5HT 
potency may have previously been underestimated.
952-127 Essential Improvements to a Working, Isolated 
Rat Heart Mode) With Hemodynamic and NMR 
Spectroscopic Monitoring
R.J.F. Houston, C.J.A.M. Zeebregts, S.H. Skotnicki, A. Heerschap,
F.W.A. Verheugt, B. Oeseburg. University of Nijmegen, NL-6500HB 
Nijmegen, The Netherlands
To the cardiac surgeon, effective cardioprotection means recovery of heart 
function after ischemia, and an experimental model to test cardioprotective 
techniques should offer some means of predicting damage. Loss of phospho- 
creatlne (PCr) is a very early indicator of myocardial metabolic compromise; 
w e therefore developed an ejecting rat heart model in which the left atrium 
and aorta are cannulated, the perfusate is a suspension of bovine erythro­
cytes in artificial plasma to ensure adequate oxygen and metabolite supply, 
and in contrast to a Langendorff model, the heart performs real work inside 
the bore of an NMR spectrometer (typically 55 mL.min-1 aortic output against 
13 kPa; see diagram),
Langendorff
buffer
-20 mL.min*
+50 mL.min'1
Aortic flow 
(Af=)v 
pressure P
PxQ
= 0
Working
erythrocyte
suspension
+ 5 5  m L m ln-1
PXÒ « 
Work rate
+20 mL.min-1 6 ¿+5 mL.min-1
A new phosphorus NMR spectrum can be obtained every five minutes, 
giving on-line, nondestructive measurement of high-energy and inorganic 
phosphates and intracellular pH. During pilot experiments, the hearts hung in 
air at 37flC and typically recovered 90% of left ventricular output after 20 min 
ischemia. However, we have now introduced a miniature temperature sensor 
into the right ventricle, and with the heart immersed in a thermostatically 
controlled bath, and a heat exchanger in the Langendorff perfusion line to 
maintain real normothermia (389C), this degree of damage occurs after only 
10 min, at which time PCr reaches a very low level (<25% control); in air at 
37eC with relative humidity less than 100%, rapid cooling occurs. Immersion 
of the heart in erythrocyte-free solution also depresses functional output, 
while immersion in the erythrocyte suspension has no effect on work output. 
A tightly-controlled, repeatable model such as this is essential for basic 
research into cardioprotection.
Bleeding With Coronary Artery Bypass Surgery 
(CABG) in Patients Treated with a Platelet 
Glycoprotein llb/llla Inhibitor
B.E. Tardiff, J.E, Tcheng, S. Peck, A.M. Llncoff, R.A. Harrington, R.M. Califf, 
E.J. Topol, for the IMPACT-11 Investigators. Duke University, Durham, NC, 
USA
There is concern that the use of llb/llla inhibitors for angioplasty (PTCA) 
or unstable angina may be associated with increased bleeding if CABG is 
Jater required. We examined perioperative bleeding and blood product use 
in patients undergoing in-hospital CABG in the IMPACT II trial (evaluating 
Integrilin in PTCA). Hematological change variables (pre-bypass value minus 
in-hospital nadir), blood product use, bleeding Index (Bl, AHct/3 + # units 
transfused), and clinical outcomes at 30 days are shown. Values are median 
(25th, 75th percentiles) or n (%).
Integrilin hi dose 
(n = 37)
Integrilin lo dose 
(n = 44)
é
Fiacebo 
(n = 53)
AHgb 6(4,7) 5(4.6) 5(4,7)
AHct 18(14,20) 16(11,19) 17(13,22)
Aplatelets x 1000 60(21,103) 69(-6,113) 87(32,129)
PRBC units 2(0,4) 2(0,4) 2(0.4)
FFP units 0(0, 2) 0(0,1) 0(0,0)
platelet units 0(0,2) 0(0,2) 0(0,1)
Bl 9(6,10) 6(5,10) 7(6,10)
death (30 days) 2(5%) 1(2%) 4(8%)
Ml (30 days) 10(27%) 11 (25%) 17(32%)
In a multivariable model {including clinical characteristics), treatment arm 
was not a significant predictor of Bl.
Conclusion: Use of Integrilin, a potent platelet Inhibitor, to manage is­
chemic complications of PTCA does not seem to be associated with more 
severe bleeding with later CABG or more frequent transfusions. 30-day out­
comes also appeared favorable in this small sample.
952-1341 Complete Myocardial Revascularisation with 
Trans myocardial Laser as an Adjunct to CABG 
without Cardiopulmonary Bypass
N. Trehan, R. Bapna, A. Mishra, Y. Mehta, V.M. Kohli, Y. Mlshra, M. Mishra. 
Escorts Heart Institute And Research Centre, New Delhi, India
There Is a large group of patients where conventional bypass grafting cannot 
be adequately accomplished in all territories because of diffuse disease or 
lack of distal targets. Many of these patients are at high risk because of se­
vere systemic disease, aortic atherosclerosis, advanced age etc. TMLR as 
an adjunct to CABG offers a new approach whereby total myocardial revas­
cularisation can be achieved in these patients without the use of CPB. TMLR 
combined with CABG on beating heart without CPB has been performed on 
56 patients. Age ranged from 37-81 years (mean 56.17 ±  10.36). The mean 
LVEF was 44.59 ±  10.04. Nine patients had EF < 35%. Mean number of ves­
sels bypassed were 1.09. IMA was used in all cases. 4 patients were In renal
